Detailed View
KNSA - Kiniksa Pharmaceuticals Interna
Latest filing: 2026-09-30 | Reporting: gaap
Market Cap
7,665,455,104
Adj EBIT (TTM)
146,017,000
Enterprise Value
7,096,697,104
Last Price
97.56
Earnings Yield
2.06%
Return on Capital
18.80%
Capital
776,888,000
1Y Price Chart
Last Price: $97.56
1Y Change: 147.43%
As of 2026-10-29 | 1Y Change: 147.43%
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-09-30 | 10-Q | 2026 | 285,970,000 | 54,236,000 |
| 2026-06-30 | 10-Q | 2026 | 243,600,000 | 27,194,000 |
| 2026-03-31 | 10-Q | 2026 | 214,266,000 | 29,267,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 202,127,000 | 19,768,000 |
| 2025-09-30 | 10-Q | 2025 | 180,855,000 | 24,021,000 |
| 2025-06-30 | 10-Q | 2025 | 156,797,000 | 20,160,000 |
| 2025-03-31 | 10-Q | 2025 | 137,785,000 | 13,272,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 122,536,000 | -19,299,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.